Asensus Surgical (ASXC)
(Delayed Data from AMEX)
$0.34 USD
0.00 (0.00%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $0.34 0.00 (0.15%) 4:48 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Asensus Surgical (ASXC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$0.35 | $0.35 | $0.35 | 2.94% |
Price Target
Only one analyst offered a short-term price target of $0.35 for Asensus Surgical. This represents an increase of 2.94% from the last closing price of $0.34.
Analyst Price Targets (1 )
Broker Rating
Asensus Surgical currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on two recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/16/2024 | Cantor Fitzgerald & Co | Ross Osborn | Hold | Hold |
4/4/2024 | H.C. Wainwright & Co. | Swayampakula Ramakanth | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 2 |
Average Target Price | $0.35 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 143 of 252 |
Current Quarter EPS Est: | -0.05 |